arrow
U

Uttam Kumar Nath

department of medical oncology & hematology
H指数:16
被引数:997

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identifying the angiogenic receptor expression in mantle cell lymphoma patients and murine models

鉴定套细胞淋巴瘤患者和小鼠模型中的血管生成受体表达

2026-07-240
OA
Ianalumab plus Eltrombopag in Immune Thrombocytopenia

Ianalumab plus Eltrombopag在免疫性血小板减少症中的应用

2025-12-010
PRE
De novo assembly of seven multidrug-resistant (MDR) Staphylococci genomes from biofilms of hemodialysis tunneled cuffed catheter tips of patients undergoing renal failure treatment

从接受肾功能衰竭治疗患者的血液透析隧道带 cuff 导管尖端生物膜中,对七株多药耐药(MDR)金黄色葡萄球菌基因组进行从头组装。

2025-09-010
OA
Real-World Data of Molecular Response Using Different Dosage of Upfront Generic Dasatinib in Chronic Phase Chronic Myeloid Leukemia: Single-Center Experience from India

真实世界数据:使用不同剂量初始通用达沙替尼治疗慢性期慢性粒细胞白血病的分子学反应——来自印度的单中心经验

BLOOD
IF23.1
2024-11-050
PRE
Real-World Experience with Generic Venetoclax Plus Hypomethylating Agent Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia Patients in Resource-Limited Setting: A Single-Center Study from India

真实世界经验:资源受限环境下印度单中心研究中,新诊断急性髓系白血病患者的通用型维奈克拉联合低甲基化诱导治疗的临床应用

BLOOD
IF23.1
2024-11-050
PRE
Treatment Outcomes in Acute Promyelocytic Leukemia Patients Using a Uniform ATRA plus ATO Consolidation Therapy Regimen across All Risk Groups: A Single Centre Study from India

使用统一ATRA联合ATO巩固治疗方案治疗所有风险组急性早幼粒细胞白血病患者的疗效:一项来自印度的单中心研究

BLOOD
IF23.1
2024-11-050
PRE
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病患者的治疗策略和治疗顺序: 欧洲CLL研究计划ERIC的国际研究

2024-09-170
OAAI
Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma
LEUKEMIA
IF13.4
2024-07-131
PRE
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

CLL历史上的其他恶性肿瘤: ERIC进行的一项国际多中心研究,欧洲CLL研究倡议,和谐

2023-11-016
OAAI